Microalbuminuria in type 2 diabetes: an independent predictor of cardiovascular mortality

J Beilin1, K G Stanton, V J McCann

  • 1Department of Endocrinology and Diabetes, Royal Perth Hospital, WA.

Australian and New Zealand Journal of Medicine
|August 1, 1996
PubMed
Abstract

Insights

Microalbuminuria is an independent predictor of mortality in type 2 diabetes. This study confirms that elevated urine albumin levels significantly increase the risk of cardiovascular death, even after accounting for other risk factors.

Area of Science:

  • Nephrology
  • Cardiology
  • Endocrinology

Background:

  • Microalbuminuria is linked to cardiovascular mortality in type 2 diabetes.
  • The extent to which other cardiac risk factors contribute to this association is unclear.

Purpose of the Study:

  • To examine the relationship between urine albumin excretion and cardiovascular mortality.
  • To determine if microalbuminuria is an independent risk factor for mortality in type 2 diabetes.

Main Methods:

  • Prospective longitudinal study of 666 type 2 diabetic subjects (1986-1993).
  • Measured urine albumin concentration and other cardiovascular risk factors at baseline.
  • Used Cox proportional hazards regression to analyze mortality risk, adjusting for multiple conventional risk factors.

Main Results:

  • 31.7% of subjects had microalbuminuria (urine albumin 30-300 mg/L).
  • Microalbuminuria was associated with a 1.77-fold increased risk of all-cause mortality and a 2.34-fold increased risk of cardiovascular mortality.
  • Diastolic blood pressure, HDL cholesterol, and glycated hemoglobin were also significant predictors of cardiovascular mortality.

Conclusions:

  • Microalbuminuria is confirmed as an independent predictor of mortality in type 2 diabetes.
  • This association persists despite the presence of conventional cardiovascular risk factors.

Related Concept Videos

Carbohydrate Metabolism01:36

Carbohydrate Metabolism

Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...